Atrial Fibrillation Trial, Recruiting NCT07492524 Sponsor: Jiangsu Taizhou People's Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07492524
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The trial is based at village clinics that are willing and able to provide coordinated care to patients with atrial fibrillation (an irregular heart rhythm condition)
  • The village clinic serving the patient must cover patients from 3 to 5 nearby villages, with doctors trained in basic telemedicine (remote medical care using technology)
  • Patients must be between 65 and 80 years of age
  • Patients must have atrial fibrillation confirmed by a heart tracing test (ECG), or hold a diagnosis certificate for the condition issued by a specialist
  • Patients must have a confirmed or documented history of heart failure, established through heart ultrasound testing and/or a blood marker test (NT-proBNP), with specific measurements meeting defined thresholds (confirm with trial site for exact values)
  • Patients must be managed by a village clinic located near where they live
  • Patients must be able to understand the study procedures and sign a written consent form

Who may not be able to join:

  • People whose life expectancy is estimated to be less than 12 months
  • People with severely reduced kidney function (confirm with trial site for exact measurements) or who are currently on dialysis
  • People whose heart failure is caused by a treatable underlying condition, such as thyroid disease affecting the heart, heart problems caused by anaemia, or uncorrected heart defects present from birth
  • People who have been identified as needing a pacemaker but have not yet had one fitted
  • People with a chronic lung condition (COPD) that has led to a serious type of breathing failure known as type II respiratory failure
  • People with a diagnosed mental illness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13814010410

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jiangsu Taizhou People's Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
30 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in MAGGIC Heart Failure Risk Score; Composite Cardiovascular Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov